Clinical Trial: Multicenter Phase I Study of HRS-6208 in Patients With Solid Tumors

U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06727812) titled 'Multicenter Phase I Study of HRS-6208 in Patients With Solid Tumors' on Dec. 06.

Brief Summary: This is an open, multicenter Phase I study to evaluate the safety and tolerability of HRS-6208 in patients with advanced solid tumors.

Study Start Date: Dec., 2024

Study Type: INTERVENTIONAL

Condition: Solid Tumors

Intervention: DRUG: HRS-6208

HRS-6208.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shandong Suncadia Medicine Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....